Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Adrenal glands delay the start of winter fur growth in mink.

Lower ghrelin levels and certain gene variations may increase acne risk.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Changing light exposure boosts hormone levels and antioxidant activity, improving cashmere growth in goats.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Microextraction techniques improve hormone testing while being environmentally friendly.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

PCOS has many symptoms, with high androgen levels being the most common.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.